IMRT 2018
… SBRT in low and intermediate risk patients
“It is ASTRO’s opinion that data supporting the use of SBRT for prostate cancer have matured to a point where
SBRT could be considered an appropriate alternative for patients with low to intermediate risk disease”
Made with FlippingBook - professional solution for displaying marketing and sales documents online